MedPath

Efficacy of subendometrial PRP injection for FET cycle of RIF patients

Phase 2
Conditions
Infertility.
N97.8
Female inf
Registration Number
IRCT20091012002576N29
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
60
Inclusion Criteria

RIF patients
Have good quality embryo
Having signed informed consent
Age 20-40 years

Exclusion Criteria

Severe male infertility
BMI>30
Uncontrolled hypothyroidism
User of corticosteroids
User of glucose control agents
CNS tumour
Uterine malformation
Cavity distorting lesions
Severe endometriosis
Liver disease
Asherman syndrome

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath